IDH1突变-话题@MedSci

#IDH1突变#

11篇内容 | 955人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1379411, encodeId=a12d13e941126, content=<a href='/topic/show?id=86379420cd' target=_blank style='color:#2F92EE;'>#IDH1突变#</a>, objectTitle=Neurology病例：Ollier病中经组织病理学证实的颅内内生软骨瘤/低级别软骨肉瘤和IDH1突变的弥漫性胶质瘤, objectType=article, longId=734545, objectId=f843e3454596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f843e3454596, replyNumber=0, likeNumber=27, createdTime=2022-08-06, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f843e3454596, moduleTitle=Neurology病例：Ollier病中经组织病理学证实的颅内内生软骨瘤/低级别软骨肉瘤和IDH1突变的弥漫性胶质瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f843e3454596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379410, encodeId=550513e9410ea, content=<a href='/topic/show?id=86379420cd' target=_blank style='color:#2F92EE;'>#IDH1突变#</a>, objectTitle=NEJM：艾伏尼布联合阿扎胞苷治疗IDH1突变AML的3期研究结果公布，患者获益显著, objectType=article, longId=724783, objectId=51e5e2478377, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51e5e2478377, replyNumber=0, likeNumber=40, createdTime=2022-04-23, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51e5e2478377, moduleTitle=NEJM：艾伏尼布联合阿扎胞苷治疗IDH1突变AML的3期研究结果公布，患者获益显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51e5e2478377)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379409, encodeId=988a13e9409b2, content=<a href='/topic/show?id=86379420cd' target=_blank style='color:#2F92EE;'>#IDH1突变#</a>, objectTitle=JAMA Oncol：Ivosidenib (AG-120)可改善经治IDH1突变肝内胆管细胞癌患者的总生存：III期ClarIDHy研究最终OS分析结果, objectType=article, longId=217781, objectId=606a21e7812d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=606a21e7812d, replyNumber=0, likeNumber=33, createdTime=2021-09-29, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=606a21e7812d, moduleTitle=JAMA Oncol：Ivosidenib (AG-120)可改善经治IDH1突变肝内胆管细胞癌患者的总生存：III期ClarIDHy研究最终OS分析结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=606a21e7812d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379408, encodeId=1cd913e94084f, content=<a href='/topic/show?id=86379420cd' target=_blank style='color:#2F92EE;'>#IDH1突变#</a>, objectTitle=PNAS：雷公藤变成为靶向药物？有望用于治疗IDH1突变的癌症, objectType=article, longId=205801, objectId=4ba0205801a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ba0205801a7, replyNumber=0, likeNumber=37, createdTime=2021-01-18, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ba0205801a7, moduleTitle=PNAS：雷公藤变成为靶向药物？有望用于治疗IDH1突变的癌症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ba0205801a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379407, encodeId=a2b413e940761, content=<a href='/topic/show?id=86379420cd' target=_blank style='color:#2F92EE;'>#IDH1突变#</a>, objectTitle=Blood：IDH1突变通过干扰血红素合成和红细胞生成导致髓系发育不良, objectType=article, longId=204135, objectId=6cb1204135c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6cb1204135c1, replyNumber=0, likeNumber=44, createdTime=2020-12-06, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6cb1204135c1, moduleTitle=Blood：IDH1突变通过干扰血红素合成和红细胞生成导致髓系发育不良, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6cb1204135c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379406, encodeId=7bf113e9406e2, content=<a href='/topic/show?id=86379420cd' target=_blank style='color:#2F92EE;'>#IDH1突变#</a>, objectTitle=Radiology：IDH1突变胶质瘤在超高分辨率3D MR波谱下会有什么发现？, objectType=article, longId=192032, objectId=d5d5192032ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d5d5192032ba, replyNumber=0, likeNumber=38, createdTime=2020-04-13, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d5d5192032ba, moduleTitle=Radiology：IDH1突变胶质瘤在超高分辨率3D MR波谱下会有什么发现？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5d5192032ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379405, encodeId=028513e9405f7, content=<a href='/topic/show?id=86379420cd' target=_blank style='color:#2F92EE;'>#IDH1突变#</a>, objectTitle=NEJM：Ivosidenib治疗IDH1突变型AML疗效喜人, objectType=article, longId=139938, objectId=f21013993802, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f21013993802, replyNumber=0, likeNumber=50, createdTime=2018-06-06, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f21013993802, moduleTitle=NEJM：Ivosidenib治疗IDH1突变型AML疗效喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f21013993802)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379404, encodeId=863c13e940414, content=<a href='/topic/show?id=86379420cd' target=_blank style='color:#2F92EE;'>#IDH1突变#</a>, objectTitle=Leukemia：维生素C能诱导IDH1突变的急性髓系白血病的表观遗传修饰, objectType=article, longId=127599, objectId=099312e5996f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=099312e5996f, replyNumber=0, likeNumber=37, createdTime=2018-01-26, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=099312e5996f, moduleTitle=Leukemia：维生素C能诱导IDH1突变的急性髓系白血病的表观遗传修饰, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=099312e5996f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379403, encodeId=ca3513e9403ae, content=<a href='/topic/show?id=86379420cd' target=_blank style='color:#2F92EE;'>#IDH1突变#</a>, objectTitle=Cancer Res：烷基化的化学治疗剂替莫唑胺能够诱发IDH1突变肿瘤的代谢应激并强化NAD+损耗介导的细胞毒性, objectType=article, longId=102901, objectId=463910290169, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=463910290169, replyNumber=0, likeNumber=34, createdTime=2017-06-23, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=463910290169, moduleTitle=Cancer Res：烷基化的化学治疗剂替莫唑胺能够诱发IDH1突变肿瘤的代谢应激并强化NAD+损耗介导的细胞毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=463910290169)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379402, encodeId=7f5813e9402bb, content=<a href='/topic/show?id=86379420cd' target=_blank style='color:#2F92EE;'>#IDH1突变#</a>, objectTitle=Neurology：IDH1突变型脑胶质瘤患者癫痫发作率高, objectType=article, longId=96207, objectId=73f69620e79, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73f69620e79, replyNumber=0, likeNumber=38, createdTime=2017-04-19, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73f69620e79, moduleTitle=Neurology：IDH1突变型脑胶质瘤患者癫痫发作率高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73f69620e79)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379401, encodeId=9cdf13e9401d1, content=<a href='/topic/show?id=86379420cd' target=_blank style='color:#2F92EE;'>#IDH1突变#</a>, objectTitle=Cancer Cell：IDH1突变有望成为神经胶质瘤治疗靶点, objectType=article, longId=60720, objectId=f80760e20e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f80760e20e2, replyNumber=0, likeNumber=34, createdTime=2015-12-18, rootId=0, userName=diushouji, userId=c192448, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f80760e20e2, moduleTitle=Cancer Cell：IDH1突变有望成为神经胶质瘤治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f80760e20e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

IDH1突变

2020-05-29

diushouji (审核中...)

前往app查看评论内容

#IDH1突变#

Neurology病例：Ollier病中经组织病理学证实的颅内内生软骨瘤/低级别软骨肉瘤和IDH1突变的弥漫性胶质瘤

2022-08-06

diushouji (审核中...)

前往app查看评论内容

#IDH1突变#

NEJM：艾伏尼布联合阿扎胞苷治疗IDH1突变AML的3期研究结果公布，患者获益显著

2022-04-23

diushouji (审核中...)

前往app查看评论内容

#IDH1突变#

JAMA Oncol：Ivosidenib (AG-120)可改善经治IDH1突变肝内胆管细胞癌患者的总生存：III期ClarIDHy研究最终OS分析结果

2021-09-29

diushouji (审核中...)

前往app查看评论内容

#IDH1突变#

PNAS：雷公藤变成为靶向药物？有望用于治疗IDH1突变的癌症

2021-01-18

diushouji (审核中...)

前往app查看评论内容

#IDH1突变#

Blood：IDH1突变通过干扰血红素合成和红细胞生成导致髓系发育不良

2020-12-06

diushouji (审核中...)

前往app查看评论内容

#IDH1突变#

Radiology：IDH1突变胶质瘤在超高分辨率3D MR波谱下会有什么发现？

2020-04-13

diushouji (审核中...)

前往app查看评论内容

#IDH1突变#

NEJM：Ivosidenib治疗IDH1突变型AML疗效喜人

2018-06-06

diushouji (审核中...)

前往app查看评论内容

#IDH1突变#

Leukemia：维生素C能诱导IDH1突变的急性髓系白血病的表观遗传修饰

2018-01-26

diushouji (审核中...)

前往app查看评论内容

#IDH1突变#

Cancer Res：烷基化的化学治疗剂替莫唑胺能够诱发IDH1突变肿瘤的代谢应激并强化NAD+损耗介导的细胞毒性

2017-06-23

diushouji (审核中...)

前往app查看评论内容

#IDH1突变#

Neurology：IDH1突变型脑胶质瘤患者癫痫发作率高

2017-04-19

diushouji (审核中...)

前往app查看评论内容

#IDH1突变#

Cancer Cell：IDH1突变有望成为神经胶质瘤治疗靶点

2015-12-18

科室
- - 订阅+
  - 更多科室
工具
服务